Randomized Pilot Study of Chaplain-Delivered Compassion Meditation for Patients Receiving Stem Cell Transplantation
| Registry | NCT06328699 |
|---|---|
| Status | Active not recruiting |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: none, supportive care |
| Enrollment | 50 (Actual) |
| Sponsor | Emory University (Other); collaborators: National Cancer Institute (NCI), National Center for Complementary and Integrative Health (NCCIH) |
| Conditions | Lymphoma, Multiple Myeloma |
| Interventions | Spiritual Therapy, Best Practice (Procedure, other) |
| Dates | start 2023-10-30, primary completion 2024-11-13, completion 2026-11-15 (estimated), first posted 2024-03-25, last updated 2026-08-26 |
| Locations | 1 site in United States |
Related Papers Related Patents Related Grants Related Experts
All trials for Lymphoma All trials for Multiple Myeloma All trials of Spiritual Therapy All trials of Best Practice
This clinical trial tests the feasibility, implementation and acceptability of chaplain delivered compassion meditation in order to improve spiritual care for patients receiving stem cell transplantation. Hospital chaplains play a vital role in delivering emotional and spiritual care to a broad range of both religious and non-religious patients for a wide variety of stressors, and extensive research indicates that spiritual consults impact patient outcomes and satisfaction. Compassion meditation is a secularized, research-based mindfulness and compassion meditation program designed to expand and strengthen compassion for self and others. Practices include training in attentional stability and increased emotional awareness, as well as targeted reflections to appreciate one's relationship with self and others. By centering the mind, controlling debilitating ruminative thoughts, and cultivating personal resiliency and an inclusive and more accurate understanding of others. Engaging in chaplain delivered compassion meditation may improve the spiritual care for patients receiving stem cell transplantation.
PRIMARY OBJECTIVE:
I. To examine the feasibility, adoption, extent of implementation, acceptability and fidelity of chaplain-delivered compassion-centered spiritual health (CCSH).
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients receive chaplain-led compassionate centered spiritual health sessions over 30 minutes, twice per week for up to 2 weeks.
ARM II: Patients receive a traditional chaplain consultation and care upon request, per standard of care.
After completion of study treatment, patients are followed up at 80-100 days and 6 months post treatment.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Arm I (Chaplain delivered compassion meditation) | Experimental | Procedure: Spiritual Therapy | Patients receive chaplain led compassionate centered spiritual health sessions over 30 minutes, twice per week for up to 2 weeks. |
| Arm II (Traditional chaplain consultation) | Active comparator | Other: Best Practice | Patients receive a traditional chaplain consultation and care upon request, per standard of care. |
Sex: All, ages: 18 Years to any, accepts healthy volunteers
Inclusion Criteria: * PATIENT: Within 6 weeks of scheduled hematopoietic stem cell transplant (HSCT) * PATIENT: > 18 years of age * PATIENT: Speak and read English * CHAPLAIN: Emory Healthcare chaplain Exclusion Criteria: * PATIENT: Patients will be excluded if they are cognitively impaired, on a ventilator, or are in a room requiring enteric precautions or airborne precautions (e.g., use of an N-95 mask requiring fit-testing) to enter * CHAPLAIN: There will be no exclusion criteria and no consequence to the chaplains for refusing to volunteer
| Facility | City | Country | Status |
|---|---|---|---|
| Emory University Hospital/Winship Cancer Institute | Atlanta, Georgia | United States |
NIH grants: K01AT010488, P30CA138292